Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
PUT
Snap
SNAP
$9.35B
| $157K | ﹤0.01% |
+18,000
| New | +$188K |
|
2902
CALL
Utz Brands
UTZ
$1.26B
| $156K | ﹤0.01% |
+11,100
| New | +$153K |
|
2903
PUT
Medifast
MED
$134M
| $155K | ﹤0.01% |
11,500
-33,000
| -74% | -$496K |
|
2904
PUT
GigaCloud Technology
GCT
$1.8B
| $152K | ﹤0.01% |
+10,700
| New | +$195K |
|
|
WBA
2905
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $152K | ﹤0.01% |
13,600
-78,400
| -85% | -$851K |
|
|
MTAL
2906
DELISTED
Metals Acquisition
MTAL
| $152K | ﹤0.01% |
+15,910
| New | +$168K |
|
2907
PUT
Huntington Bancshares
HBAN
$34.4B
| $152K | ﹤0.01% |
10,100
-2,800
| -22% | -$45.1K |
|
2908
CALL
Chemours
CC
$2.32B
| $150K | ﹤0.01% |
+11,100
| New | +$184K |
|
2909
Embecta
EMBC
$283M
| $148K | ﹤0.01% |
+11,596
| New | +$186K |
|
2910
CALL
Cenovus Energy
CVE
$59.3B
| $143K | ﹤0.01% |
+10,300
| New | +$148K |
|
|
PR
2911
CALL
Permian Resources
PR
$19.8B
| $143K | ﹤0.01% |
+10,300
| New | +$147K |
|
2912
CALL
Iris Energy
IREN
$14.2B
| $138K | ﹤0.01% |
22,600
+6,500
| +40% | +$63.3K |
|
|
BAND
2913
Bandwidth Inc
BAND
$1.49B
| $137K | ﹤0.01% |
10,433
-34,759
| -77% | -$569K |
|
2914
Babcock & Wilcox
BW
$1.15B
| $136K | ﹤0.01% |
202,746
| – | – |
|
|
HAPN
2915
PUT
Happen Inc
HAPN
$2.11B
| $135K | ﹤0.01% |
+13,100
| New | +$176K |
|
2916
10x Genomics
TXG
$8.31B
| $134K | ﹤0.01% |
15,393
-184,618
| -92% | -$2.33M |
|
2917
Outset Medical
OM
$78.8M
| $133K | ﹤0.01% |
12,028
-2
| -0% | -$24 |
|
2918
UNIFI
UFI
$142M
| $132K | ﹤0.01% |
27,465
-46
| -0.2% | -$258 |
|
|
HAPN
2919
CALL
Happen Inc
HAPN
$2.11B
| $131K | ﹤0.01% |
+12,700
| New | +$170K |
|
2920
PUT
Fluence Energy
FLNC
$1.55B
| $127K | ﹤0.01% |
+26,100
| New | +$250K |
|
2921
NovaGold Resources
NG
$4.1B
| $123K | ﹤0.01% |
42,134
-532,757
| -93% | -$1.71M |
|
2922
CALL
Vale
VALE
$64B
| $123K | ﹤0.01% |
12,300
-111,300
| -90% | -$1.05M |
|
|
GTM
2923
PUT
ZoomInfo Technologies
GTM
$1.14B
| $122K | ﹤0.01% |
+12,200
| New | +$128K |
|
|
GES
2924
PUT
DELISTED
Guess Inc
GES
| $122K | ﹤0.01% |
11,000
-4,700
| -30% | -$56.8K |
|
2925
Ironwood Pharmaceuticals
IRWD
$682M
| $120K | ﹤0.01% |
81,795
+55,729
| +214% | +$133K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.